Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of Yakson Method and Swaddling on Pain and Physiological Parameters

26. august 2022 oppdatert av: Aslihan Hacisalihoglu, Istanbul University - Cerrahpasa (IUC)

Effects of Yakson Method Applied by Mother and Swaddling on Pain and Physiological Parameters During Heel Stick in Newborn

Type of Study: The study was planned to be conducted in a randomized controlled experimental design.

Place and Time of the Research: Institutional permission will be obtained from the Balcalı Training and Research Hospital in Adana for the collection of research data. Researchers commit to start data collection after obtaining institutional permission. The data collection process will take 1 year after obtaining the institutional permission.

48 newborns who are suited the inclusion criteria will be included in the study. Participants will be assigned to 3 groups according to randomization: Swaddling, Yakson Method, and Control.

Studieoversikt

Status

Har ikke rekruttert ennå

Intervensjon / Behandling

Detaljert beskrivelse

Total processing time and baby's crying time are calculated by watching video recordings. In order to find the total procedure time, starting from the puncture of the baby's heel, the time until the dry cotton is placed on the baby's heel after the blood collection process is completed is calculated. The heart rate and SpO2 are noted by the investigator during the heel lancing procedure. Pain assessment of infants is done by two independent neonatal nurses, apart from the researcher, by watching video recordings. The scores given by the two observers will be evaluated by making inter-observer harmony. Before the evaluation, the nurses will be trained about the scale and its evaluation.

Studietype

Intervensjonell

Registrering (Forventet)

48

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

1 sekund til 4 uker (Barn)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

Inclusion Criteria for Newborn:

  • Born at term (38-42 weeks)
  • Healthy newborn
  • Absence of congenital anomaly
  • No analgesic or sedative medication has been administered in the last 6 hours
  • Parent's consent for inclusion in the study in accordance with the consent form

Inclusion Criteria for Mother:

  • Mother's willingness to participate in the study
  • The mother can be mobilized and not have a physical disability (so that she can appyl Yakson therapy for her baby)
  • Being communicative

Exclusion Criteria:

  • Babies whose blood cannot be drawn on the first try

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Yakson Method Group
  • The mother is informed about the benefits of the Yakson method.
  • Yakson method is taught practically to the mother. Education continues until the researcher is sure that the mother has done the method correctly. The mother starts the application 10 minutes before the heel lancing is done and continues for another 5 minutes after the heel lancing is done. During the application, the baby is recorded with the camera. Just before starting the Yakson method (initial assessment), at 10 minutes of the Yakson method (just before the heel lancing), during the heel lancing while the Yakson method is in progress, and 5 minutes after the procedure (just before the end of the tender touch), the newborn's pain and physiological parameters are evaluated. Evaluation results are recorded in the application observation form.
Yakson Method and Swaddling
Eksperimentell: Swaddling Group
  • Parents are informed about the research and verbal consent is obtained.
  • Written consent is obtained with an informed consent form.
  • The Mother-Baby Information Form is filled.
  • Babies are fed 1 hour before blood collection.
  • And researher swaddling the baby
Yakson Method and Swaddling
Ingen inngripen: Control Group

Parents are informed about the research and verbal consent is obtained.

  • Written consent is obtained with an informed consent form.
  • The Mother-Baby Information Form is filled.
  • Babies are fed 1 hour before blood collection.
  • Before starting the heel lancing, a pulse oximeter probe will be attached to the baby's left big toe.
  • Blood is taken from the right heel of the foot.
  • During the application, the baby is recorded with the camera.
  • Evaluation results are recorded in the application observation form.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Neonatal Infant Pain Scale (NIPS):
Tidsramme: 1 year
This scale was developed in 1993 by Lawrence et al. for premature and newborns. The scale measures the infant's response to pain behaviorally. The total score of the scale ranges from 0 to 7, and scores higher than 3 indicate the presence of pain.
1 year

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Forventet)

1. september 2022

Primær fullføring (Forventet)

1. september 2023

Studiet fullført (Forventet)

1. september 2023

Datoer for studieregistrering

Først innsendt

25. august 2022

Først innsendt som oppfylte QC-kriteriene

26. august 2022

Først lagt ut (Faktiske)

29. august 2022

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

29. august 2022

Siste oppdatering sendt inn som oppfylte QC-kriteriene

26. august 2022

Sist bekreftet

1. august 2022

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • IstanbulUC-AHacisalihoglu

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Kliniske studier på Nonfarmacology method

3
Abonnere